Novo Nordisk invests in new insulin-production plant in China
| By Gerald Ondrey
Novo Nordisk A/S (Bagsvaerd, Denmark; www.novonordisk.com) today announced a major investment in a new insulin production plant in Tianjin, China. The plant has been designated Novo Nordisk’s primary production base in the Asia Pacific region and…